Ligand validation:5S79

PZO: PYRAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5S79_PZO_B_506	50%	41%	0.169	0.92	1.06	1.28	-	-	2	0	100%	0.48
5S79_PZO_B_505	36%	36%	0.24	0.933	1.2	1.38	-	-	1	0	100%	0.58
5S79_PZO_B_507	29%	57%	0.227	0.884	0.25	1.35	-	-	0	0	100%	0.5
5S79_PZO_B_508	25%	60%	0.222	0.856	0.51	0.99	-	-	4	0	100%	0.5
5CDU_PZO_B_404	98%	34%	0.051	0.977	1.56	1.14	1	-	0	0	100%	1
1N8K_PZO_B_378	95%	36%	0.074	0.978	1.17	1.45	1	-	9	0	100%	1
8G2X_PZO_A_404	67%	33%	0.123	0.932	1.26	1.5	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.